GENERIC MEDICINES · KASDAP HEALTHCARE
Generic medicines are the backbone of India's healthcare accessibility story — yet misconceptions about their quality persist. This guide sets the record straight.
What Are Generic Medicines?
A generic medicine contains the same active ingredient, dose, and dosage form as a branded reference medicine. Manufacturers must demonstrate bioequivalence before regulatory approval — meaning the generic is absorbed at the same rate and extent as the original.
Generic medicines are not inferior versions of branded products. They are therapeutically equivalent alternatives priced 30–80% lower by not bearing original R&D costs.
India's Generic Medicine Landscape
India's pharmaceutical industry produces over 60,000 generic formulations across 60 therapeutic categories. This diversity creates both opportunity and risk — affordable medicines for all, but significant quality variation between manufacturers. Choosing generics from WHO-GMP certified sources is therefore critical.
Bioequivalence: The Science Behind Generic Approval
In a bioequivalence study, healthy volunteers receive both the generic and the reference product. Blood samples measure drug concentration over time. The generic is approved if its pharmacokinetic parameters fall within 80–125% of the reference — ensuring the same therapeutic outcomes when patients switch.
Narrow Therapeutic Index Medicines
For antiepileptics, anticoagulants, and thyroid hormones, even small variations within the accepted range may be clinically significant. Careful monitoring is required after any brand switch in these categories.
Common Misconceptions Addressed
Misconception 1: Generics Use Inferior Ingredients
False. Generic medicines use the same API meeting identical pharmacopoeial specifications for identity, purity, and potency. Excipients may differ but do not affect efficacy when bioequivalence is demonstrated.
Misconception 2: Generics Are Less Effective
False. Multiple meta-analyses across therapeutic categories have found no meaningful clinical outcome differences between branded and bioequivalent generic medicines.
Misconception 3: All Generics Are Equal Quality
This is the most important point. While all approved generics must meet bioequivalence requirements, manufacturing quality varies enormously between producers. A generic from a WHO-GMP certified, internationally audited facility represents a fundamentally different risk profile than one from an unverified local producer.
Jan Aushadhi: Expanding Affordable Access
The Pradhan Mantri Bhartiya Janaushadhi Pariyojana has established over 10,000 Jan Aushadhi Kendras offering generics at 50–90% less than branded alternatives. For patients with chronic conditions requiring lifelong medication, the annual savings are substantial and transformative.
Kasdap Healthcare's Generic Quality Commitment
Every product in the Kasdap Healthcare portfolio is sourced exclusively from WHO-GMP certified manufacturing partners with verified batch documentation. We believe affordable healthcare and quality healthcare are not mutually exclusive.
Partner with Kasdap for quality-assured generic medicines
